Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication | October 2015
Canada’s Patented Medicines Notice of Compliance Regulations (PM(NOC) Regulations) are loosely based on the U.S. Hatch-Waxman regime and are meant to link patent protection with the drug approval process. As required by the PM(NOC) Regulations, Health Canada maintains a Patent Register (similar to the U.S. Orange Book).
Read more (pdf 1,006kb)
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023